Discovery, drinks and canapes.
Learn the latest on the University’s commitment to impactful research and industry engagement, and meet the teams supporting commercialisation and collaboration within the University.
You will have an opportunity to ask questions about the commercialisation process, and understand the services available to you within the University.
We will be joined by guest speaker, Lusia Guthrie, University alumni, former founder and CEO of LBT Innovations Ltd and commercialisation advocate.
Lusia will share some of her own commercialisation experiences, culminating with the recent FDA approval of LBT’s proprietary imaging and software technology, APAS®. This cutting edge technology was the result of a collaborative research project between LBT and the University, and is the first technology of its kind in the world! A true testament to the importance of translational research.
- Biography: Lusia Guthrie
As a founder and former chief executive of an ASX-listed company, Lusia is an experienced healthcare industry executive with strong leadership skills and international industry links and networks. She has a passion and proven track record in technology commercialization, embracing the entire process from concept through engineering design, product development and market launch.
Lusia has over 35 years' experience in the healthcare industry. She began her professional career as a medical laboratory scientist and laboratory manager, changing direction after 10 years to join pharmaceutical company F H Faulding & Co, where she spent the next 13 years. She has executive level operations and manufacturing management experience, with expertise in product development, production and supply chain management, project management, industrial relations, quality systems and regulatory compliance.
Lusia is a co-founder of LBT Innovations Limited. She is an experienced leader of a company that has developed breakthrough technology, managed relationships with global diagnostics companies and continues to innovate and branch into new areas. As CEO, Lusia raised significant funds for LBT and oversaw the development and commercialisation of two innovative diagnostic platforms for the automation of clinical microbiology testing.
She is a Member of the Australian Institute of Company Directors and has held several non-executive board appointments. Lusia has previously served as a member of the Manufacturing Consultative Council (MCC) for the State Government of South Australia, a member of the Future Manufacturing Industry Innovation Council (FMIIC) for the Commonwealth Department of Industry, Innovation, Science, Research and Tertiary Education, and on the Assessment Panel for the Medical Device Commercialisation Program (MDCP) at the SA Government's Department of Trade and Economic Development.
She currently serves on the Board of MedDev SA Alliance for the SA Government Department of State Development and the ACVT Industry Advisory Board (School of Computer Science, University of Adelaide). In June 2016 Lusia was appointed Chairman of Clever Culture Systems AG, the LBT Innovations joint venture with Hettich AG Switzerland.
Date: Friday 11 November 2016
Time: 3:00 - 5:00pm
Venue: Brasilia Cafe
Ground Floor, Nexus, 10 Pulteney Steet Adelaide
RSVP via this LINK**
Refreshments and canapes will be provided.
Questions? Contact Kirsten Bernhardt